drugset / Trial / NCT00005833

S9923 R115777 in Treating Patients With Advanced Colorectal Cancer

NCT00005833

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of R115777 in treating patients who have recurrent or advanced colorectal cancer.

Timeline

Start
2000-06
Primary completion
2006-07
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject tipifarnib Small molecule 300 mg Oral

Indications